{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:50:44Z","timestamp":1789865444700,"version":"4.0.1"},"reference-count":26,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1517\/14740338.6.3.235","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T13:23:46Z","timestamp":1178285026000},"page":"235-239","source":"Crossref","is-referenced-by-count":62,"title":["Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities"],"prefix":"10.1517","volume":"6","author":[{"given":"George J","family":"Kontoghiorghes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2007,5,4]]},"reference":[{"key":"CIT0001","first-page":"63","volume":"61","year":"1983","journal-title":"WHO Bull."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2174\/092986705774463003"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326080-00003"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90264-X"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2174\/0929867033457610"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13309-0"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003253350"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2004.09.002"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2006.42.10.1009901"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06455.x"},{"key":"CIT0011","unstructured":"Exjade (deferasirox) tablets for oral suspension. Prescribing information. Novartis Pharmaceutical Corp. USA (NDA 21-882). October (2006):1-12."},{"key":"CIT0012","unstructured":"Exjade (deferasirox) tablets for oral suspension update. Keeping you informed about changes to the Exjade prescribing information. Novartis Oncology, USA (EXJ-OT-0623-A). November (2006):1."},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92978-B"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(71)90300-0"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2006.05.005"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14085-8"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1080\/03630260600642567"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02357-6"},{"key":"CIT0019","first-page":"1187","volume":"91","author":"TELFER","year":"2006","journal-title":"Haematologica"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2948"},{"key":"CIT0021","author":"HENTER","year":"2007","journal-title":"Blood"},{"key":"CIT0022","first-page":"1799","volume":"20","author":"SHASHATY","year":"2006","journal-title":"Oncology"},{"key":"CIT0023","first-page":"1332","volume":"40","author":"KONTOGHIORGHES","year":"1990","journal-title":". Arzneimittel-Forschung\/Drug Research"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05202.x"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67205-4"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2005.030.12.942323"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.6.3.235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T09:07:51Z","timestamp":1481620071000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.6.3.235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,5,4]]},"published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1517\/14740338.6.3.235"],"URL":"https:\/\/doi.org\/10.1517\/14740338.6.3.235","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}